Grunnet M - Search Results

1

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.

Langkjer ST, Kenholm J, Jensen JD, Wedervang K, Brixen AT, Grunnet M, Stenbygaard L, Gilje B, Danø H, Glavicic V, Jacobsen EH, Brems-Eskildsen AS, Kruse HL, Dongsgaard T, Neimann J, Geisler J. Langkjer ST, et al. Among authors: grunnet m. Future Oncol. 2019 Aug;15(22):2561-2569. doi: 10.2217/fon-2019-0124. Epub 2019 Jun 19. Future Oncol. 2019. PMID: 31215242 Free article. Clinical Trial.

2

Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers.

Høgdall D, O'Rourke CJ, Dehlendorff C, Larsen OF, Jensen LH, Johansen AZ, Dang H, Factor VM, Grunnet M, Mau-Sørensen M, Oliveira DVNP, Linnemann D, Boisen MK, Wang XW, Johansen JS, Andersen JB. Høgdall D, et al. Among authors: grunnet m. Clin Cancer Res. 2020 Nov 1;26(21):5655-5667. doi: 10.1158/1078-0432.CCR-19-2700. Epub 2020 Sep 15. Clin Cancer Res. 2020. PMID: 32933994 Free PMC article.

3

Serum tumor markers in bile duct cancer--a review.

Grunnet M, Mau-Sørensen M. Grunnet M, et al. Biomarkers. 2014 Sep;19(6):437-43. doi: 10.3109/1354750X.2014.923048. Epub 2014 May 23. Biomarkers. 2014. PMID: 24857368 Review.

4

Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.

Grunnet M, Mau-Sørensen M, Brünner N. Grunnet M, et al. Scand J Gastroenterol. 2013 Aug;48(8):899-905. doi: 10.3109/00365521.2013.812235. Epub 2013 Jul 8. Scand J Gastroenterol. 2013. PMID: 23834019 Review.

5

Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients.

Grunnet M, Christensen IJ, Lassen U, Jensen LH, Lydolph M, Lund IK, Thurison T, Høyer-Hansen G, Mau-Sørensen M. Grunnet M, et al. Clin Biochem. 2014 May;47(7-8):599-604. doi: 10.1016/j.clinbiochem.2014.01.030. Epub 2014 Feb 12. Clin Biochem. 2014. PMID: 24530340

6

Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer.

Grunnet M, Christensen IJ, Lassen U, Jensen LH, Lydolph M, Knox JJ, McNamara MG, Jitlal M, Wasan H, Bridgewater J, Valle JW, Mau-Sorensen M. Grunnet M, et al. Eur J Cancer. 2015 Jul;51(11):1381-8. doi: 10.1016/j.ejca.2015.04.011. Epub 2015 May 9. Eur J Cancer. 2015. PMID: 25971532

7

TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas.

Grunnet M, Calatayud D, Schultz NA, Hasselby JP, Mau-Sørensen M, Brünner N, Stenvang J. Grunnet M, et al. Scand J Gastroenterol. 2015 Apr;50(4):485-94. doi: 10.3109/00365521.2014.980318. Epub 2015 Jan 23. Scand J Gastroenterol. 2015. PMID: 25615400

8

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Grunnet M, Sorensen JB. Grunnet M, et al. Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6. Lung Cancer. 2012. PMID: 22153832 Review.

9

A fatal case of primary basaloid squamous cell carcinoma in the intrahepatic bile ducts.

Kirkegaard J, Grunnet M, Hasselby JP. Kirkegaard J, et al. Among authors: grunnet m. Case Rep Pathol. 2014;2014:410849. doi: 10.1155/2014/410849. Epub 2014 Oct 7. Case Rep Pathol. 2014. PMID: 25400964 Free PMC article.

10

Inhibition of the K_Ca2 potassium channel in atrial fibrillation: a randomized phase 2 trial.

Holst AG, Tomcsányi J, Vestbjerg B, Grunnet M, Sørensen US, Diness JG, Bentzen BH, Edvardsson N, Hohnloser SH, Bhatt DL, Dorian P. Holst AG, et al. Among authors: grunnet m. Nat Med. 2024 Jan;30(1):106-111. doi: 10.1038/s41591-023-02679-9. Epub 2023 Dec 13. Nat Med. 2024. PMID: 38092897 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page